Finance
Markets
No recent trading data. The last price we hold for SYK is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

SYK

stock Healthcare Medical Devices
Stryker Corporation
$295.00 +1.70 (+0.58%) Delayed · quoted 47d ago
Mixed 47% Steady

What the indicators say

Mixed 1 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
38
0oversold 30overbought 70100

RSI 38 — soft momentum, not yet oversold.

EMA 21 $306.70
Below
Near-term trend is down
SMA 50 $318.19
Below
Medium-term trend is down
SMA 200 $355.26
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $291.44
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $291.74 High $297.52
Open
$295.00
+0.58%
Close
$295.00
+0.58%
52-week range where the price sits across its year
52w low $281.00 52w high $404.87
Current
$295.00
Prev close
$293.30
Volume 0.71× the 3-month average
0 avg 2× avg
Today
1.77M
3-mo avg
2.48M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Jul 30in 9 days

Recent earnings dates

  • Apr 30 82 days ago
  • Jan 29 173 days ago
  • Oct 30, 2025 264 days ago
  • Jul 31, 2025 355 days ago

Past earnings dates come from SYK’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), SYK’s fundamentals read as strong overall.

P/E ratio Fair
34.1x

At 34.1x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
12.9%

A 12.9% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
14.5%

A 14.5% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
6.8%

A 6.8% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.13

At 1.13, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.89

At 1.89, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+11.2%

Revenue grew 11.2% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+8.5%

Net income grew 8.5% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $17.1B$18.4B$20.5B$22.6B$25.1B
Net income $2.0B$2.4B$3.2B$3.0B$3.2B
Diluted EPS $5.21$6.17$8.25$7.76$8.40
Dividend / share
Total assets $34.6B$36.9B$39.9B$43.0B$47.8B
Total liabilities $19.8B$20.3B$21.3B$22.3B$25.4B
Shareholder equity $14.9B$16.6B$18.6B$20.6B$22.4B

Leadershipsynced from SEC 53d ago

  • Fink M Kathryn VP, Chief HR Officer
  • Caforio Giovanni Director
  • Maceda Emmanuel Perez Director
  • Mccoy Sherilyn S Director
  • Ruggeri Rachel Director
  • Silvernail Andrew K Director
  • Skeete Tatum Lisa M Director
  • Stryker Ronda E Director
  • Suri Rajeev Director

Officers and board are drawn from SYK’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$3.40
2026 so far
$0.881 payment
2026 projected
$3.52+3.5% vs 2025

Projection scales SYK’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 31 $0.88
  • Dec 31, 2025 $0.88
  • Sep 30, 2025 $0.84
  • Jun 30, 2025 $0.84
  • Mar 31, 2025 $0.84
  • Dec 31, 2024 $0.84
  • Sep 30, 2024 $0.80
  • Jun 28, 2024 $0.80
  • Mar 27, 2024 $0.80
  • Dec 28, 2023 $0.80
  • Sep 28, 2023 $0.75
  • Jun 29, 2023 $0.75
  • Mar 30, 2023 $0.75
  • Dec 29, 2022 $0.75
  • Sep 29, 2022 $0.69
  • Jun 29, 2022 $0.69
  • Mar 30, 2022 $0.69
  • Dec 30, 2021 $0.69
  • Sep 29, 2021 $0.63
  • Jun 29, 2021 $0.63

Recent SEC filingssynced from SEC 51d ago